Aquestive Therapeutics Inc. (AQST)
NASDAQ: AQSTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 4.62 0.00%
AQST stock chart
Technical analysisKey statistics
All statistics- Market cap
- $579.86M
- EPS (TTM)
- -$0.66
- Dividend yield
- None
- 52-week range
- 2.93 – 7.55
- Day range
- 4.53 – 4.67
- Volume / Avg
- 1.36M / 2.66M
- Beta
- —
- Shares outstanding
- 125.51M
- Next earnings
- Nov 4, 2026
52-week range
AQST stock today
Shares of Aquestive Therapeutics (AQST) finished higher on Oct 7 at $4.62, a gain of 0.22% or $0.01 per share, versus the S&P 500's 0.22% decline. Shares are 38.8% below their 52-week high of $7.55, set on Oct 20, 2025 and 57.7% above the 52-week low of $2.93, in the middle of the past year's range. AQST is down 28.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 22.6%.
Aquestive Therapeutics has posted a net loss over the last twelve months (EPS of -$0.66), so its P/E ratio is not meaningful. Aquestive Therapeutics's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Aquestive Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2018
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.10
Aquestive Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EVOEvotec SE ADR | 1.61 | -1.23% | $572.18M | vs AQST |
| STTKShattuck Labs Inc. | 5.66 | -3.50% | $567.55M | vs AQST |
| CRMDCorMedix Inc. | 7.28 | 0.00% | $567.43M | vs AQST |
| MNPRMonopar Therapeutics Inc. | 83.78 | +5.29% | $562.35M | vs AQST |
| CTMXCytomX Therapeutics Inc. | 2.55 | -0.39% | $555.64M | vs AQST |
| PHATPhathom Pharmaceuticals Inc. | 6.81 | +0.44% | $550.94M | vs AQST |
| SLNSilence Therapeutics Plc American Depository Share | 9.82 | -0.10% | $610.35M | vs AQST |
| CLYMClimb Bio Inc. | 10.71 | +0.28% | $615.14M | vs AQST |
Indexes, lists and sector
Largest Health Care stocks
Aquestive Therapeutics stock FAQ
What is Aquestive Therapeutics's stock price today?
AQST last traded at $4.62 as of Oct 7, 4:00 PM EDT, up 0.22% on the day. Prices are delayed at least 15 minutes.
When is Aquestive Therapeutics's next earnings date?
Aquestive Therapeutics is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.10.
What is the AQST 52-week high?
The 52-week high for AQST is $7.55 and the 52-week low is $2.93. The stock is currently 38.8% below its high.